Dextrose — 50%, Solution for injection, tray of 25 × 50 mL vials

Dextrose — 50%, Solution for injection, tray of 25 × 50 mL vials

Dextrose (DEXTROSE MONOHYDRATE) is a solution for injection for intravenous use. Dextrose (50%) Injection is indicated for the treatment of insulin-induced hypoglycemia (e.g., hyperinsulinemia, insulin shock) in adults and pediatric patients 2 years of age and older. Dextrose Injection (50%) is indicated for the treatment of insulin-induced hypoglycemia (e.g., hyperinsulinemia, insulin shock) in adults and pediatric patients 2 years of age and older. ( 1 )

• Active ingredient or product type: DEXTROSE MONOHYDRATE
• Strength/concentration: 50%
• Dosage form and route: Solution for injection, Intravenous
• Exact package presentation: tray of 25 × 50 mL vials
• NDC/item number: 0409-6648-02
• Manufacturer: PFIZER PHARM
• Storage/handling: Protect from freezing. Store at 20°C to 25°C (68°F to 77°F) [See USP Controlled Room Temperature.] Distributed by Hospira, Inc., Lake Forest, IL 60045 USA LAB-1027-9.0 Logo
• Status: Rx only

Important safety information: • Hyperglycemia or Hyperosmolar Syndrome : Monitor blood and urine glucose; administer insulin as needed. ( 5.1 ) • Hypersensitivity Reactions : Monitor for signs and symptoms and discontinue infusion immediately if reaction occurs. ( 5.2 ) • Phlebitis and Thrombosis : Remove catheter as soon as possible if thrombophlebitis develops. ( 2.1 , 5.3 ) • Electrolyte Imbalance and Fluid Overload : Monitor changes in fluid balance, electrolyte concentrations, and acid-base balance during administration

Refer to the current product labeling for complete indications, preparation or administration instructions, contraindications, warnings, precautions, and storage requirements.